ArticleNPJ Parkinson's disease2017
Variable frequency of
Erratum issuedAbstract read
In one paragraph
Article in NPJ Parkinson's disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta-Analysis.Movement disorders : official journal of the Movement Disorder Society · 2024Pooled it
- Association of LRRK2 p.A419V with Parkinson's Disease in East Asians and analysis of age at onset.NPJ Parkinson's disease · 2026Article
- ThemedRxiv : the preprint server for health sciences · 2025Article
- Article
- Absence of theFrontiers in aging neuroscience · 2025Article
- Parkinson's Disease Gene Screening in Familial Cases from Central and South America.Movement disorders : official journal of the Movement Disorder Society · 2024Article
- Towards a Global View of Parkinson's Disease Genetics.Annals of neurology · 2024Review
- Genetic risk variants in New Yorkers of Puerto Rican and Dominican Republic heritage with Parkinson's disease.NPJ Parkinson's disease · 2023Article
- The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.Genes · 2023Review
- LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis.International journal of molecular sciences · 2023Article
- Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease.Biomolecules · 2023Review
- A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects.Genome medicine · 2022Article
- Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.Frontiers in neuroscience · 2022Review
- Mapping the Diverse and Inclusive Future of Parkinson's Disease Genetics and Its Widespread Impact.Genes · 2021Review
- Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain.Molecules (Basel, Switzerland) · 2021Article
- Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.Annals of neurology · 2021Article
- Dementia in Latin America: Paving the way toward a regional action plan.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021Article
- Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease.Frontiers in neurology · 2021Article
- Genetic characterization of Parkinson's disease patients in Ecuador and Colombia.Parkinsonism & related disorders · 2020Article
- ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population.Cerebellum (London, England) · 2019Article
Corrections and comments
- Erratum issued
Authors and funding
24 authors.
Mario Cornejo-OlivasNeurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Luis TorresMovement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Mario R Velit-SalazarNeurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Miguel Inca-MartinezNeurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Pilar MazzettiNeurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Carlos CosentinoMovement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Federico MicheliHospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina.
Claudia PerandonesHospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina.
Elena DieguezNeurology Institute, Universidad de la Republica, Montevideo, Uruguay.
Victor RaggioDepartment of Genetics, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay.
Vitor TumasRibeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil.
Vanderci BorgesMovement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, SP Brazil.
Henrique B FerrazMovement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, SP Brazil.ORCID 0000-0002-3821-1407
Carlos R M RiederHospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.ORCID 0000-0003-2950-7211
Artur Shumacher-SchuhHospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Carlos Velez-PardoNeruroscience Research Group, Medical Research Institute, Universidad de Antioquia, Medellin, Colombia.
Marlene Jimenez-Del-RioNeruroscience Research Group, Medical Research Institute, Universidad de Antioquia, Medellin, Colombia.
Francisco LoperaNeruroscience Research Group, Medical Research Institute, Universidad de Antioquia, Medellin, Colombia.
Jorge Chang-CastelloDepartment of Genetics, School of Medicine, Universidad de Guayaquil, Hospital Luis Vernaza, Guayaquil, Ecuador.
Brennie Andreé-MunozService of Neurology, Hospital Luis Vernaza, Guayaquil, Ecuador.
Sarah WaldherrVeterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA USA.
Dora YearoutVeterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA USA.
Cyrus P ZabetianVeterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA USA.
Ignacio F MataVeterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA USA.
Funding
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7MNorthern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9MUsing Multiplex Families to map Genes that Modify Susceptibility and Age at OnsetR01NS065070 · NINDS · UNIVERSITY OF WASHINGTON · PI ZABETIAN, CYRUS P · 2009 to 2012
$2.0MGenetic Risk Factors for Parkinson's DiseaseI01BX000531 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI ZABETIAN, CYRUS P · 2009 to 2013
–BLRD VA I01 BX000531FIC NIH HHS R25 TW009345NIA NIH HHS T32 AG052354NINDS NIH HHS R01 NS065070
Abstract
Mutations in
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.